#clinical trial — Wednesday, March 18, 2026 (2 items)
| 0 | 💬 0 |
Safety, tolerability, and immunogenicity of a 31-valent pneumococcal conjugate vaccine (VAX-31) in healthy adults aged 50 years and older from the USA: a phase 1/2, double-blinded, active-controlled, parallel-group, dose-finding randomised clinical trial.
(linkinghub.elsevier.com)
|
Lancet Infectious Diseases 2026-03-18 | #vaccination #clinical trial #immunogenicity #safety #pneumococcal | |
| 0 | 💬 0 |
Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmap.
(linkinghub.elsevier.com)
|
Lancet Infectious Diseases 2026-03-18 | #vaccination #clinical trial #tb |